Humalog

Humalog Caution For Usage

insulin lispro

Manufacturer:

Eli Lilly

Distributor:

Zuellig
/
Agencia Lei Va Hong
Full Prescribing Info
Caution For Usage
Special precautions for disposal and other handling: Any unused product or waste material should be disposed of in accordance with local requirements.
Instructions for use and handling: Vial: The vial is to be used in conjunction with an appropriate syringe (100 unit markings).
a) Preparing a dose: Inspect the Humalog solution. It should be clear and colourless. Do not use Humalog if it appears cloudy, thickened, or slightly coloured or if solid particles are visible.
i) Humalog: 1. Wash hands.
2. If using a new vial, flip off the plastic protective cap, but do not remove the stopper.
3. If the therapeutic regimen requires the injection of basal insulin and Humalog at the same time, the two can be mixed in the syringe. If mixing insulins, refer to Mixing Humalog with longer-acting Human Insulins as follows and Incompatibilities.
4. Draw air into the syringe equal to the prescribed Humalog dose. Wipe the top of the vial with an alcohol swab. Put the needle through the rubber top of the Humalog vial and inject the air into the vial.
5. Turn the vial and syringe upside down. Hold the vial and syringe firmly in one hand.
6. Making sure the tip of the needle is in the Humalog, withdraw the correct dose into the syringe.
7. Before removing the needle from the vial, check the syringe for air bubbles that reduce the amount of Humalog in it. If bubbles are present, hold the syringe straight up and tap its side until the bubbles float to the top. Push them out with the plunger and withdraw the correct dose.
8. Remove the needle from the vial and lay the syringe down so that the needle does not touch anything.
ii) Mixing Humalog with longer-acting Human Insulins (see Incompatibilities): 1. Humalog should be mixed with longer-acting human insulins only on the advice of a doctor.
2. Draw air into the syringe equal to the amount of longer-acting insulin being taken. Insert the needle into the longer-acting insulin vial and inject the air. Withdraw the needle.
3. Now inject air into the Humalog vial in the same manner, but do not withdraw the needle.
4. Turn the vial and syringe upside down.
5. Making sure the tip of the needle is in the Humalog, withdraw the correct dose of Humalog into the syringe.
6. Before removing the needle from the vial, check the syringe for air bubbles that reduce the amount of Humalog in it. If bubbles are present, hold the syringe straight up and tap its side until the bubbles float to the top. Push them out with the plunger and withdraw the correct dose.
7. Remove the needle from the vial of Humalog and insert it into the vial of the longer-acting insulin. Turn the vial and syringe upside down. Hold the vial and syringe firmly in one hand and shake gently. Making sure the tip of the needle is in the insulin, withdraw the dose of longer-acting insulin.
8. Withdraw the needle and lay the syringe down so that the needle does not touch anything.
b) Injecting a dose: 1. Choose a site for injection.
2. Clean the skin as instructed.
3. Stabilise the skin by spreading it or pinching up a large area. Insert the needle and inject as instructed.
4. Pull the needle out and apply gentle pressure over the injection site for several seconds. Do not rub the area.
5. Dispose of the syringe and needle safely.
6. Use of the injection sites should be rotated so that the same is not used more than approximately once a month.
c) Mixing insulins: Do not mix insulin in vials with insulin in cartridges. See Incompatibilities.
Cartridge: To prevent the possible transmission of disease, each cartridge must be used by one patient only, even if the needle on the delivery device is changed.
Humalog cartridges are to be used with a CE marked pen as recommended in the information provided by the device manufacturer.
a) Preparing a dose: Inspect the Humalog solution. It should be clear and colourless. Do not use Humalog if it appears cloudy, thickened, or slightly coloured or if solid particles are visible.
The following is a general description. The manufacturer's instructions with each individual pen must be followed for loading the cartridge, attaching the needle and administering the insulin injection.
b) Injecting a dose: 1. Wash hands.
2. Choose a site for injection.
3. Clean the skin as instructed.
4. Remove outer needle cap.
5. Stabilise the skin by spreading it or pinching up a large area. Insert the needle as instructed.
6. Press the knob.
7. Pull the needle out and apply gentle pressure over the injection site for several seconds. Do not rub the area.
8. Using the outer needle cap, unscrew the needle and dispose of it safely.
9. Use of injection sites should be rotated so that the same site is not used more than approximately once a month.
c) Mixing insulins: Do not mix insulin in vials with insulin in cartridges. See Incompatibilities.
KwikPen: Always check the pack and the label of the pre-filled pen for the name and type of the insulin when getting from the pharmacy. Make sure to get the Humalog KwikPen that the physician has told to use.
Always use Humalog KwikPen exactly as the physician has told. Check with the physician if unsure.
Preparing Humalog KwikPen: Humalog is already dissolved in water, no need to mix it. But use it only if it looks like water. It must be clear, have no colour and no solid pieces in it. Check each time the patient injects himself/herself.
Getting the KwikPen ready to use (Please see user manual): First wash the hands.
Read the instructions on how to use the pre-filled insulin pen. Follow the instructions carefully.
Use a clean needle. (Needles are not included.)
Prime the KwikPen before each use. This checks that insulin comes out and clears the air bubbles from the KwikPen. There may still be some small air bubbles left in the pen, these are harmless. But if the air bubbles are too large it may affect the insulin dose.
Injecting Humalog: Before making an injection, clean the skin as instructed. Inject under the skin, as instructed. Do not inject directly into a vein. After the injection, leave the needle in the skin for five seconds to make sure the patient has taken the whole dose. Do not rub the area of injection. Make sure to inject at least half an inch (1 cm) from the last injection and that the patient 'rotates' the places of injection, as what has been taught. It doesn't matter which injection site the patient uses, either upper arm, thigh, buttock or abdomen, the Humalog injection will still work quicker than soluble human insulin.
Do not administer Humalog by the intravenous route. Inject Humalog as the physician or nurse has taught. Only the physician can administer Humalog by the intravenous route. He will only do this under special circumstances such as surgery or if the patient is ill and the glucose levels are too high.
After injecting: As soon as the patient has done the injection, unscrew the needle from the KwikPen using the outer needle cap. This will keep the insulin sterile and stop it leaking. It also stops air entering the pen and the needle clogging. Do not share the needles. Do not share the pen. Replace the cap on the pen.
Further injections: Every time the patient uses a KwikPen, use a new needle. Before every injection, clear any air bubbles. The patient can see how much insulin is left by holding the KwikPen with the needle pointing up. The scale on the cartridge shows about how many units are left.
Do not mix any other insulin in the disposable pen. Once the KwikPen is empty, do not use it again. Please get rid of it carefully, the pharmacist or diabetes nurse will tell the patient how to do this.
Using Humalog in an infusion pump: Only certain CE-marked insulin infusion pumps may be used to infuse insulin lispro. Before infusing insulin lispro, the manufacturers instructions should be studied to ascertain the suitability or otherwise for the particular pump. Read and follow the instructions in the product literature supplied with the infusion pump.
Be sure to use the correct reservoir and catheter for the pump.
Change the infusion set every 48 hours. Use aseptic technique when inserting the infusion set.
In the event of a hypoglycaemic episode, the infusion should be stopped until the episode is resolved. If repeated or severe low blood glucose levels occur, notify the physician or clinic and consider the need to reduce or stop the insulin infusion.
A pump malfunction or obstruction of the infusion set can result in a rapid rise in glucose levels. If an interruption to insulin flow is suspected, follow the instructions in the product literature and if appropriate, notify the physician or clinic.
When used with an insulin infusion pump, Humalog should not be mixed with any other insulin.
Incompatibilities: Humalog preparations should not be mixed with insulins produced by other manufacturers or with animal insulin preparations. This medicinal product must not be mixed with other medicinal products except those mentioned previously.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in